Work

193TiP Phase 3 study of epacadostat plus pembrolizumab with or without platinum-based chemotherapy vs pembrolizumab plus chemotherapy for first-line metastatic non-small cell lung cancer (mNSCLC): ECHO-306/KEYNOTE-715

Year: 2018

Type: article

Source: Journal of Thoracic Oncology

DOI: 10.1016/s1556-0864(18)30466-0

Authors: M. Garassino, S. Rubin, Y. Zhao, Y. Luo, A. Samkari, R. Hui

Institutions: Fondazione IRCCS Istituto Nazionale dei Tumori, Incyte (United States), Merck & Co., Inc., Rahway, NJ, USA (United States), The University of Sydney, Westmead Hospital

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2797398139

FWCI:

Cites:

Cited by:

Related to: 10